INTRODUCTION
The nucleolar and coiled-body phosphoprotein 1 (NOLC1, also called Nopp140) family of proteins is characterized by a conserved C-terminal SRP40 domain. NOLC1 is a phosphoprotein composed of N-and C-terminal domains and a unique central repeated domain consisting of alternating acidic and basic amino acid clusters and localized in the nucleolus (1). The greatest steady state concentrations of vertebrate NOLC1 localize within the dense fibrillar component (DFC) of nucleoli (2).
NOLC1 was first identified as a nuclear localization signal-binding protein and is thought to be a chaperone for shuttling between the nucleolus and cytoplasm (2, 3). NOLC1 plays an essential role in the synthesis of rRNA and the biosynthesis of ribosomes. NOLC1 is not an integral part of small nucleolar ribonucleoproteins (snoRNPs) but interacts with box C/D and box H/ACA snoRNPs, guiding site-specific 2'-O-methylation and pseudouridylation of pre-rRNAs, respectively (4-6). Previous studies have shown that rDNA transcription and pre-rRNA processing are sequential and activated by newly synthesized rRNA. They coordinate and depend upon the interaction of upstream binding factor (UBF) and snoRNPs. The complexes, composed of NOLC1, chromatin and UBF, can collect nucleolar proteins to engage in activities during early ribosome biogenesis. The rRNA intermediate products are then transferred from the NOLC1-containing islets to the surrounding granular component compartment (GC) for further maturation (7, 8) . NOLC1 rapidly shuttles between the nucleus and the cytoplasm, perhaps to facilitate the import of nucleolar ribosome assembly factors or the export of nucleolar products. Knockdown of NOLC1 blocks pre-rRNA synthesis (9), and NOLC1 may also play a role in the maintenance of nucleolar integrity. When an exogenous NOLC1 N-terminus is expressed, cell nucleoli structures become altered, mislocalize the endogenous Pol I and shut off cellular rRNA gene transcription. When NOLC1 is overexpressed, cells demonstrate an enlarged nucleolus (5).
The PKA-phosphorylated NOLC1s also have a transcription factor-like activity that activates the α-1 acid glycoprotein gene (AGP) by interacting with C/EBP-β (10, 11). Recently, NOLC1 has been demonstrated to participate in the regulation of nasopharyngeal carcinoma progression by binding to the promoter of the TP53 region and working synergistically with TP53 to regulate MDM2 expression (12). This result indicates that NOLC1 plays a role as an oncogene in tumorigenesis.
Given that NOLC1's function is complex, it is likely that control of NOLC1 occurs at multiple levels. However, the mechanisms regulating NOLC1 expression remain incompletely characterized. In this report, we cloned the sequentially truncated NOLC1 promoter and demonstrated that the region between −110 and +38 of the NOLC1 promoter is essential for its basal transcription in HepG2 cells. Importantly, we observed a critical role for the transcription factors NF-κB and cAMP response element-binding protein (CREB) in the regulation of NOLC1. These findings provide new insight into the regulation of NOLC1 expression. http://bmbreports.org BMB reports The region between −110 and +38 was analyzed with Promoter Scan and TFSEARCH. Two putative cis-elements, NF-κB and CREB, were discovered.
RESULTS

The highest expression of NOLC1 mRNA in HepG2 cells
To investigate differences in the expression of NOLC1 in different cell lines, we performed real-time PCR assay for NOLC1 gene expression in hepatic cell lines: HepG2, Huh-7, QGY-7701, SMMC-7721, BEL-7402 and two non-hepatic cell lines: HeLa and CaP. Expression of the NOLC1 gene was highest in the HepG2 cells (Fig. 1) . Therefore, we elected to use the HepG2 cell line for further study.
Cloning and analysis of the NOLC1 promoter
We characterized the 5'-flanking region upstream of the NOLC1 gene using the NCBI database. There are no typical TATA boxes, but a high GC content and a number of transcription factor binding sites are presumed to exist. To identify and analyze the NOLC1 promoter, a 1,882-bp genomic DNA fragment was amplified from genomic DNA isolated from HepG2 cells. The putative NOLC1 promoter region was cloned upstream of the firefly luciferase gene into the reporter plasmid pGL4.10 Basic; this construct was named P1 and served as the template for further shortened NOLC1 promoter constructs. Luciferase assays were performed 24 hours after the transfection of HepG2 cells. Compared to pGL4.10 Basic, the luciferase activity of P1 increased significantly (about 100-fold), suggesting that the NOLC1 promoter was active in HepG2 cells. Next, our aim was to determine which regions of the promoter were important for transcriptional activity. To accomplish this task, we generated five additional constructs containing sequentially truncated promoter fragments ( Fig.  2A) . As shown in Fig. 2B , there was an increase in activity when the 5' end was shortened from P1 to P2, suggesting that the regulatory elements located from −1,844 to −996 might be acting as potential silencers. However, there was a loss of promoter activity with P6. Serial deletion analysis therefore suggested that P5, including a 148-bp fragment of the promoter (−110 to 38), contained the requisite sequences important for transcriptional activity.
Identification of NF-κB and CREB binding sites
We searched Promoter Scan (http://www-bimas.cit.nih.gov/ molbio/proscan/) and TFSEARCH (http://www.cbrc.jp/research/ db/TFSEARCH.html) to identify putative transcription factor binding sites. Based on our scans for consensus transcription factor binding motifs, two major cis-acting elements, with the highest scores for NF-κB and CREB, were present within the minimal promoter region (−110 to +38). The NF-κB binding site was found between −71 and −61, and the CREB binding site was found between −29 and −22. Sequences of the minimal promoter and transcription factor binding sites are provided in Fig. 2C .
Specific binding of NF-κB and CREB transcription factors to the NOLC1 proximal promoter
To explore whether NF-κB and CREB could bind the NOLC1 promoter, electrophoretic mobility shift assays (EMSA) were performed. The first oligonucleotide chosen for EMSA contained sequences that matched a consensus NF-κB binding site. The nuclear extracts from the HepG2 cells showed strong binding to a wild-type probe containing an NF-κB binding site
